Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies-Reference-Cited by-同舟云学术

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies

Published:2018-10-29 Issue:7 Volume:25 Page:1580-1591
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Fava Maurizio,Thase Michael E.,Trivedi Madhukar H.^ORCID,Ehrich Elliot,Martin William F.,Memisoglu Asli,Nangia Narinder,Stanford Arielle D.,Yu Miao,Pathak Sanjeev

Funder

Alkermes

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

http://www.nature.com/articles/s41380-018-0284-1.pdf

Reference49 articles.

1. Baldessarini RJ, Forte A, Selle V, Sim K, Tondo L, Undurraga J, et al. Morbidity in depressive disorders. Psychother Psychosom. 2017;86:65–72.

2. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10:e1001547.

3. Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry. 2007;8:67–104.

4. Machado-Vieira R, Henter ID, Zarate CA Jr. New targets for rapid antidepressant action. Prog Neurobiol. 2017;152:21–37.

5. Papakostas GI. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry. 2009;70 (suppl 6):16–25.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kappa Opioid Receptor Activation Induces Epigenetic Silencing of Brain-Derived Neurotropic Factor via HDAC5 in Depression;ACS Chemical Neuroscience;2024-08-27

2. Mu-opioid receptor activation in the habenula modulates synaptic transmission and depression-like behaviors;Neurobiology of Disease;2024-08

3. Case report: Dezocine’s rapid and sustained antidepressant effects;Frontiers in Pharmacology;2024-07-18

4. New and emerging treatments for major depressive disorder;BMJ;2024-07-08

5. Therapeutic Potential of Buprenorphine in Depression: A Meta-Analysis of Current Evidence;Journal of Clinical Medicine Research;2024-03